Do Bees and Wasps Have the Same Venom?

Bee venom and wasp venom are not the same. They share a handful of enzyme families, but their signature toxins, their dominant peptides, and even the type of phospholipase they rely on most heavily are distinct. The two venoms evolved along separate lineages to serve different ecological strategies, and that divergence shows up at every level, from what the sting injects into your skin to how your immune system reacts to it. The overlap is real enough to cause diagnostic headaches for allergists, but the chemistry underneath is more different than most people assume.

What Bee Venom Contains

Honey bee venom is built around a small, potent peptide called melittin. Melittin makes up roughly half the dry weight of the venom and is responsible for much of the immediate pain and tissue destruction a sting causes. It punches holes in cell membranes, which triggers inflammation, damages red blood cells, and produces that familiar burning sensation. Alongside melittin, bee venom contains phospholipase A2, histamine, hyaluronidase, catecholamines, and serotonin.¹ Phospholipase A2, often abbreviated PLA2, is the major allergenic enzyme in bee venom and a key driver of the inflammatory cascade. Hyaluronidase acts as a spreading agent, breaking down connective tissue so the other components can penetrate deeper into the wound.

Bumblebees, which are close relatives of honey bees, produce a venom that is recognizably similar. A proteomic study of bumblebee venom found that about 72% of its components had a counterpart in honey bee venom, which makes sense given both their shared ancestry and their similar defensive needs.² But even between these closely related bees, the remaining 28% consisted of species-specific toxins that likely evolved in response to each species’ particular set of predators and threats. If two bee species can diverge that much, the gap between bees and wasps is considerably wider.

What Wasp Venom Contains

The signature peptide in wasp venom is not melittin but mastoparan, a shorter peptide that works differently at the cellular level. Wasp venom also contains wasp kinins, chemotactic peptides, and bradykinin-like peptides as its major peptide components.³ In social wasps like yellow jackets and paper wasps, these peptides work together to cause the local swelling and redness typical of a sting by increasing blood vessel permeability. On top of the peptides, wasp venom carries its own set of allergenic proteins, including phospholipase A1, hyaluronidase, antigen 5, and serine proteases.⁴

Mastoparan disrupts cells by a mechanism that overlaps somewhat with melittin: both are membrane-active peptides that insert themselves into the lipid bilayer of cells and destabilize it. But mastoparan also triggers mast cells to release histamine, which amplifies the allergic and inflammatory response. Researchers have shown that mastoparans can permeabilize the membranes of bacteria, red blood cells, and mast cells, depending on concentration.⁵ In lab settings, these peptides create short-lived pore-like defects in artificial membranes, which helps explain their rapid cell-killing ability.⁶

The Phospholipase Split

One of the cleanest chemical dividing lines between bee and wasp venom is which type of phospholipase dominates. Bees lean heavily on phospholipase A2, while wasps and ants rely on phospholipase A1.⁷ Both enzymes attack cell membranes by chewing up phospholipids, but they cut at different positions on the molecule, and structurally they are unrelated proteins. This matters for allergy diagnosis and treatment. A person whose immune system has sensitized to bee PLA2 is reacting to a protein that simply does not exist in meaningful quantities in wasp venom, and vice versa. The phospholipase distinction is one of the reasons allergists need to figure out which insect actually stung you before starting immunotherapy.

Despite the enzyme difference, the overall enzymatic toolkit of bees and wasps shares a family resemblance. Both venoms contain hyaluronidase, both have some form of phospholipase, and both carry small biogenic amines. A comparative review noted that bee and wasp venoms have similar enzymatic composition in broad terms, but a significant difference in peptide composition, with wasps favoring mastoparan and bradykinins where bees favor melittin.⁸ So the enzymatic backbone is loosely parallel, but the peptide layer on top, which drives most of the sting’s immediate effects, is quite different.

Why Allergy Tests Often Light Up for Both

If the venoms are so different, why do so many sting-allergy patients test positive for both honey bee and wasp sensitivity? Roughly 30 to 50% of people with insect venom allergy have IgE antibodies that react with both honey bee and yellow jacket venom.⁹ That sounds like the venoms must share a lot, but the reality is more complicated. A major cause of the double-positive result is not the venom proteins themselves but the sugar molecules attached to them. These cross-reactive carbohydrate determinants, shared across many insect proteins, trick IgE antibodies into binding to venom components from species the person was never actually stung by.

Researchers have been working to separate genuine double sensitization from these carbohydrate-driven false positives. By producing venom allergens in cell lines that cannot attach the culprit sugar (a specific fucose modification), scientists showed that much of the apparent cross-reactivity disappears. The honeybee hyaluronidase, known as Api m 2, turned out to retain real allergenic punch even without those sugars, meaning it is a true allergen beyond its carbohydrate coat. The yellow jacket hyaluronidases, on the other hand, showed mostly carbohydrate-driven reactivity, raising questions about how important they actually are as allergens on their own.⁹ Using recombinant allergens produced without confounding sugars, diagnostic testing can now better distinguish whether someone is truly allergic to both venoms or just testing positive because of these shared sugar structures.¹⁰ Getting this right is not academic: venom immunotherapy involves injecting gradually increasing doses of the offending venom, and treating someone for the wrong insect wastes years of effort.

Cross-Reactivity Within the Wasp Family

People often talk about “wasp venom” as though it were one thing, but the wasp family itself contains meaningful variation. Yellow jackets (genus Vespula) and hornets (genus Dolichovespula and Vespa) are both vespid wasps and share closely related allergens. Their antigen 5 proteins share about 69% of their amino acid sequence, and their hyaluronidases are 92% identical, making cross-reactivity between yellow jacket and hornet stings quite strong.¹¹ Paper wasps (genus Polistes) are more distant relatives. Their antigen 5 shares only about 60% sequence identity with yellow jacket antigen 5, and the immunological cross-reactivity drops accordingly.

This gradient matters clinically. If you are allergic to yellow jacket stings, there is a high chance you will also react to a hornet sting. The reverse is also true. But a paper wasp allergy does not predict a yellow jacket reaction nearly as reliably. At a broader level, bees and vespid wasps share just one common allergen, hyaluronidase, and even then the two versions have limited protein-level similarity. Vespids also carry antigen 5, which bees lack entirely. Below about 70% sequence identity between corresponding allergens, immunological cross-reactivity drops to barely detectable levels.¹²

Different Stingers, Different Delivery

The venoms are delivered through mechanically different equipment, which affects how much venom gets into the wound and whether the insect can sting again. A honey bee’s lancets are lined with prominent barbs that increase in size along the shaft. These barbs catch on skin tissue, and when the bee pulls away, the stinger, venom sac, and associated muscles rip free from the bee’s body. The detached apparatus keeps pumping venom into the wound even after the bee has died and departed.¹³

Paper wasps and yellow jackets also have barbs on their lancets, but the barbs are smaller and structured differently. In paper wasps, the two lancets overlap in a chiral, spiral-like arrangement that keeps the barbs tucked inside the stylet sheath. The barbs do not protrude far enough to hook into tissue the way a honey bee’s do, so the wasp can withdraw and sting again.¹³ This is why the folk wisdom holds: a bee stings once and dies, while a wasp stings repeatedly. The venom is delivered through a central hollow canal in both cases, but the retention mechanism is the key practical difference.

The bee’s sacrificial sting has a chemical dimension too. When the stinger pulls free, it releases alarm pheromone, primarily a compound called isopentyl acetate, which rapidly alerts nearby guard bees to join the defense.¹⁴ The sting essentially marks the target for further attack. This chemical signaling system evolved alongside the barbed stinger as part of a colonial defense strategy that trades an individual worker’s life for the colony’s survival.

Immunotherapy and Why the Venom Source Matters

Venom immunotherapy, in which a patient receives gradually increasing doses of purified venom to build tolerance, is the standard treatment for people at risk of life-threatening sting reactions. Here, the bee-wasp distinction has very practical consequences. A systematic analysis of observational studies found that adverse reactions during treatment were far more common with bee venom than with wasp venom: about 14% of patients undergoing bee venom immunotherapy experienced systemic reactions during treatment, compared with roughly 3% of those receiving wasp venom immunotherapy.¹⁵ The higher reactogenicity of bee venom immunotherapy likely reflects the greater allergenic potency of certain bee venom components, particularly PLA2 and melittin, at the doses used during buildup. This difference means allergists may adjust protocols, spacing, and pre-medication strategies depending on which venom the patient needs.

Therapeutic Research Heading in Different Directions

The chemical differences between bee and wasp venom have pushed pharmaceutical researchers down separate paths. On the bee side, melittin has attracted the most interest. Its ability to destroy cell membranes has led to research on antimicrobial and anticancer applications. Apamin, a much smaller bee venom peptide that crosses the blood-brain barrier and blocks certain potassium channels, has drawn attention in neuroscience research.

On the wasp side, mastoparan has been explored as a potential antimicrobial agent. It kills a broad spectrum of bacteria, including some that have developed resistance to conventional antibiotics. The challenge is that mastoparan is not very selective: it damages bacterial membranes and mammalian cell membranes by similar mechanisms. Researchers have tried modifying mastoparan’s structure to improve selectivity, including tweaking its electrical charge, stabilizing its shape, and altering its fat-solubility. So far, gains in antibacterial potency tend to come at the cost of increased toxicity to human cells, and vice versa.⁸ Both venom peptides illustrate a general problem in venom-derived drug development: the very property that makes a toxin effective against target cells, membrane disruption, tends to make it dangerous to your own cells too.

What Else Comes With the Sting

Venom is not the only thing that enters the wound. Researchers investigating the microbial cargo delivered through stings found that honey bees and wasps carry detectably different sets of bacteria on and around their stinging apparatus. Wasp and hornet stings transmitted opportunistic pathogens, including Enterobacter and Klebsiella species known for multidrug resistance, that were not found in honey bee sting samples.¹⁶ This does not mean every wasp sting causes an infection, but it adds another layer to the bee-versus-wasp distinction: the microbial hitchhikers differ, and in rare cases a sting wound that becomes infected could involve bacteria specific to the type of insect that delivered it.

There is also an energetic cost to producing venom that researchers are still mapping out. A recent study on bumblebees found that after a sting event, venom-associated proteins in the venom sac dropped and took a surprisingly long time to recover, suggesting a meaningful biological investment in replenishing the venom supply.¹⁷ This cost may help explain why many stinging insects have evolved behavioral threat displays, buzzing warnings, and other deterrents before resorting to stinging. Venom is expensive to make, and both bees and wasps seem to use it as a last resort, even if the chemical weapons they are holding back are quite different from each other.